Raelipskie Partnership Embecta Corp. Transaction History
Raelipskie Partnership
- $195 Billion
- Q1 2025
A detailed history of Raelipskie Partnership transactions in Embecta Corp. stock. As of the latest transaction made, Raelipskie Partnership holds 70 shares of EMBC stock, worth $860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70
Previous 78
10.26%
Holding current value
$860
Previous $1.61 Million
44.57%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EMBC
# of Institutions
417Shares Held
56.3MCall Options Held
54.8KPut Options Held
32.3K-
Black Rock Inc. New York, NY9.19MShares$113 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$82.8 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO3.81MShares$46.9 Million0.03% of portfolio
-
River Road Asset Management, LLC3.23MShares$39.7 Million0.58% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.72MShares$33.4 Million0.88% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $711M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...